Skip to: Content
Skip to: Site Navigation
Skip to: Search

November 21, 2008 9:53:28 PM CST

Learn about Newser Points »

« Back to the grid | Next story »

New Drug Battles Liver Cancer

Posted Jun 4, 07 7:37 CDT in US,  Business,  Science & Health 

(Newser) – An impressive clinical trial has produced what could be the first effective drug treatment for liver cancer, the New York Times reports. Nexavar, which blocks both the blood supply to the tumor and proteins that spur tumor growth, extended the lives of patients in the trial by almost three months, or 44%

"We did not have anything for these patients," said one of the principal investigators  in the trial. "Now we have an effective drug that prolongs survival." The drug, also known as sorafenib, is already approved to treat kidney cancer, so it can be prescribed "off label" to liver patients. Liver cancer is one of the most common, and deadliest, forms of the disease.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Bloodthinner Can Help Frostbite Victims

    Jun 19, 07 11:38 CDT
    Bloodthinner Can Help Frostbite Victims A clot-busting drug is remarkably effective in treating frostbite patients, according to new research from the University of Utah health center, reports the Los Angeles Times. Patients whose treatment included tissue plasmingoen activator (tPA) kept 90% of affected fingers and toes; patients treated before the drug was in use had 41% amputated. More »

  • Scientists ID New Breast Cancer Genes

    May 28, 07 7:11 CDT
    Scientists ID New Breast Cancer Genes Four newly discovered genes can increase a woman's chance of developing breast cancer by as much as 60%, say scientists who hail the isolation of the genes as the biggest advance in the field since 1994. The breakthrough raises hopes for more advanced treatment and even prevention of breast cancer and for better understanding of other cancers in the future. More »

  • Cheap Anticancer Drugs Are Ignored

    Apr 5, 07 9:51 PM CDT
    Ralph Moss writes about why inexpensive cancer treatments get no research dollars. The publisher of a newsletter that covers both conventional and alternative cancer therapies, Moss blames the inability to patent already discovered and available chemicals and drugs for the situation. More »

US NEWS LIVERCANCER 2 MW   (KRT Photos)
US NEWS LIVERCANCER 1 MW   (KRT Photos)
« Prev« Prev | Next »Next » Slideshow

Threads (
1
 of 2)

Tags

health • cancer • drugs • medicine • cancer treatment • treatment • tumor • liver cancer


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Home Stories

What is Newser?

2008 Codie Finalist

Face it: there's too much news. At Newser a team of editors and writers culls the most important stories from hundreds of U.S. and international sources and reduces them to a headline, picture, and two paragraphs. It's the Newser guarantee: we can take any report or column or video and pack what you need to know into 120 words or less. Newser's short-form aggregation, visual format, and unique information tools help you get more of the kind of news you want, in a quicker and more entertaining way. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »